Argatroban anticoagulation in obese versus nonobese patients: implications for treating heparin-induced thrombocytopenia

J Clin Pharmacol. 2007 Aug;47(8):1028-34. doi: 10.1177/0091270007302951. Epub 2007 May 24.
No abstract available

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticoagulants / administration & dosage
  • Anticoagulants / adverse effects*
  • Anticoagulants / therapeutic use*
  • Arginine / analogs & derivatives
  • Body Weight / drug effects*
  • Female
  • Heparin / adverse effects*
  • Humans
  • Male
  • Obesity / metabolism*
  • Partial Thromboplastin Time
  • Pipecolic Acids / administration & dosage
  • Pipecolic Acids / therapeutic use*
  • Platelet Count
  • Retrospective Studies
  • Sulfonamides
  • Thrombocytopenia / chemically induced*
  • Thrombocytopenia / drug therapy*
  • Treatment Outcome

Substances

  • Anticoagulants
  • Pipecolic Acids
  • Sulfonamides
  • Heparin
  • Arginine
  • argatroban